Low-cost test could pick out breast cancer patients at increased risk of relapse
Testing women’s response to hormone therapy for breast cancer given around the time of surgery…
Browsing: letrozole
ESMO 2017: LORELEI: Taselisib Boosts Breast Tumour Shrinkage
Adding taselisib to letrozole before surgery significantly improved outcomes for patients with early breast cancer…
Tucatinib progressing in pivotal trial against HER2 breast cancer
Phase 1 clinical trial data published this week in the journal Clinical Cancer Research show early promise of…
SABCS 2016: Extended letrozole therapy showed limited benefit in postmenopausal women with early-stage, HR-positive breast cancer
Five additional years of hormone therapy with letrozole following an initial five years of aromatase…
ASCO 2016: New Treatment for Advanced Breast Cancer Doubles Progression Free Survival Rates
New practice changing clinical trial results show that for postmenopausal women with advanced or metastatic…